Alopecia Associated With Treatment With Selective Serotonin Reuptake Inhibitors (SSRIs)

    January 2006 in “ Pharmacoepidemiology and drug safety ”
    Karin Hedenmalm, Anders Sundström, Olav Spigset
    Studysummary This study concluded that alopecia is a rare side effect of SSRIs, with sertraline showing a higher association compared to citalopram, particularly among women.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. The Cutaneous Serotoninergic/Melatoninergic System: Securing a Place Under the Sun ˜The œFASEB journal · 2005
    2. Telogen Effluvium: Causes, Diagnosis, and Treatment Clinical and Experimental Dermatology · 2002
    3. Hair Loss in Psychopharmacology Annals of clinical psychiatry · 2000
    4. Alopecia Due to Psychotropic Medications Annals of pharmacotherapy/˜The œannals of pharmacotherapy · 1999

    Related research 1

    1. Alopecia Associated With Treatment With Selective Serotonin Reuptake Inhibitors (SSRIs) Pharmacoepidemiology and drug safety · 2006